ITMO public health
Last update : 09/05/2017 | Version : 2 | ID : 6238
| General | |
| Identification | |
| Detailed name | Study of NorpregnAnes Coagulation |
| Sign or acronym | SNAC |
| CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | CCPPRB Bicêtre (21/12/2005), CNIL (19/12/2005) |
| General Aspects | |
| Medical area |
Biology Endocrinology and metabolism Internal medicine |
| Pathology (details) | Hormone therapy for menopause |
| Health determinants |
Medicine |
| Keywords | Oestrogen, progestin, menopause, haemostasis, thrombosis |
| Scientific investigator(s) (Contact) | |
| Collaborations | |
| Funding | |
| Funding status |
Public |
| Details | Institut National de la Santé et de la Recherche Médicale |
| Governance of the database | |
| Additional contact | |
| Main features | |
| Type of database | |
| Type of database |
Study databases |
| Study databases (details) |
Not-repeated cross-sectional studies (except case control studies) |
| Database recruitment is carried out by an intermediary |
A population file |
| Database recruitment is carried out as part of an interventional study |
No |
| Additional information regarding sample selection. | Samples selected on a voluntary basis |
| Database objective | |
| Main objective | Impact of different types of HRT on activated protein C resistance and haemostatic parameters. |
| Inclusion criteria | - Women - between 45 and 70 years of age - menopausal |
| Population type | |
| Age |
Adulthood (45 to 64 years) |
| Population covered |
General population |
| Gender |
Woman |
| Geography area |
Regional |
| French regions covered by the database |
Île-de-France |
| Detail of the geography area | Centre d'Investigations Préventives et Cliniques de Paris: SS medical examination centre |
| Data collection | |
| Dates | |
| Date of first collection (YYYY or MM/YYYY) | 2006 |
| Date of last collection (YYYY or MM/YYYY) | 2007 |
| Size of the database | |
| Size of the database (number of individuals) |
< 500 individuals |
| Details of the number of individuals | 300- 100 femmes non traitées/women no treated- 100 femmes estrogènes transdermiques + progestérone- 100 femmes estrogènes transdermiques + NOMAC |
| Data | |
| Database activity |
Data collection completed |
| Type of data collected |
Clinical data Declarative data Paraclinical data Biological data |
| Clinical data (detail) |
Direct physical measures |
| Declarative data (detail) |
Face to face interview |
| Paraclinical data (detail) | .... |
| Biological data (detail) | - blood - DNA |
| Presence of a biobank |
Yes |
| Contents of biobank |
Serum Plasma DNA |
| Details of biobank content | 500 microL plasma aliquots collected with citrate, heparin or EDTA |
| Health parameters studied |
Others |
| Other (detail) | .... |
| Procedures | |
| Data collection method | Standardised questionnaire |
| Participant monitoring |
No |
| Links to administrative sources |
No |
| Promotion and access | |
| Promotion | |
| Access | |
| Terms of data access (charter for data provision, format of data, availability delay) | Contact the scientist in charge |
| Access to aggregated data |
Access on specific project only |
| Access to individual data |
Access on specific project only |
| ABOUT | CATALOG | RESOURCES | USEFUL LINKS |
This site complies with the HONcode standard for trustworthy health information: |
8 rue de la Croix Jarry 75013 Paris Phone : +33 1 44 23 67 47 |
Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05
